Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Indoor Overheating and Physiological Strain in Older Adults With COPD

1 października 2026 zaktualizowane przez: University of Ottawa

The Impact of Extreme Heat on Individuals Living With Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial of Day-Long Passive Indoor Heat Exposure

During warm weather, homes without air conditioning can stay hot for long periods, and most heat-related health problems in Canada happen indoors rather than outdoors. Health Canada recommends that indoor temperatures not exceed 26 °C in homes occupied by people who are more susceptible to heat. That recommendation is based largely on population-level evidence, and very little is known about how susceptible individuals actually respond, physiologically, when indoor temperatures rise above it.

Older adults living with chronic obstructive pulmonary disease (COPD) are among the groups identified as more susceptible to heat. COPD involves persistent airflow limitation, reduced lung and cardiovascular reserve, and altered cellular stress responses. Despite this, no laboratory study has directly measured how adults with COPD respond to a full day spent indoors in warm conditions.

This randomized crossover trial will measure how older adults with COPD respond to two different indoor environments, each experienced for eight hours on separate days at least one week apart. One day is spent at the recommended indoor temperature limit and the other at a warmer temperature representative of conditions recorded inside Canadian homes during hot weather. Participants remain seated and rest throughout; no exercise or work is performed.

Throughout each day, the research team continuously measures core body temperature, skin temperature, heart rate, and measures blood pressure, lung function, breathlessness, thermal comfort, cognitive performance, and balance at set time points. Blood and urine samples are collected at the start and end of each day. Participants are monitored continuously by trained staff.

The results are intended to strengthen the evidence base behind Canadian indoor temperature guidance and to inform recommendations for protecting people living with chronic lung disease during hot weather.

Przegląd badań

Typ studiów

Interwencyjne

Zapisy (Szacowany)

18

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

    • Ontario
      • Ottawa, Ontario, Kanada, K1N 6N5

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

60 lat do 80 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Aged 60 to 80 years
  • Physician diagnosis of chronic obstructive pulmonary disease made at least 5 years previously
  • Clinically stable, with no acute exacerbation or active respiratory infection in the preceding 6 weeks
  • Current non-smoker
  • Able to communicate in English or French and to provide written informed consent

Exclusion Criteria:

  • Physical restriction preventing safe participation, including unstable cardiac or pulmonary disease, uncontrolled hypertension (resting blood pressure exceeding 150/95 mmHg), severe arthritis, renal impairment, active proliferative retinopathy, history of disabling stroke, or intermittent claudication
  • Recent change in medications judged by the investigators to make participation inadvisable
  • Cardiac abnormalities identified on electrocardiogram during the screening exercise test
  • Regular work or exercise in hot environments (heat acclimatized)

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Podstawowa nauka
  • Przydział: Randomizowane
  • Model interwencyjny: Zadanie krzyżowe
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Aktywny komparator: Recommended indoor temperature limit (26 °C)

Eight-hour passive seated exposure to an indoor environment maintained at 26 °C and 45% relative humidity, corresponding to the recommended upper indoor temperature limit for heat-susceptible occupants.

Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting.

Eksperymentalny: Indoor overheating (36 °C)

Eight-hour passive seated exposure to an indoor environment maintained at 36 °C and 45% relative humidity, representing warm indoor conditions recorded inside Canadian dwellings without mechanical cooling during heat events.

Day-long (8 h) passive exposure in a climate-controlled environmental chamber at a set air temperature and relative humidity. Participants remain seated or resting.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Core temperature (Peak)
Ramy czasowe: End of 8-hour exposure

Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the simulated indoor overheating exposure.

End of 8-hour exposure

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Profiles of Mood States (POMS)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem-related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives. For each individual item, participants were asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) were summed to calculate its score.

At the start (hour 0) and end of exposure (hour 8)
Environmental Symptoms Questionnaire (ESQ)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure [24, 25]. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score was calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake").

At the start (hour 0) and end of exposure (hour 8)
Orthostatic intolerance symptoms assessment
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the lying to standing tests. All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort".

At the start (hour 0) and end of exposure (hour 8)
Perceived arousal (Felt Arousal Scale)
Ramy czasowe: End of 8-hour exposure

Perceived arousal assessed using the Felt Arousal Scale, a single-item 6-point numerical rating scale on which participants respond to the question "How worked up are you?" Scores range from a minimum of 1 (low arousal) to a maximum of 6 (high arousal).

End of 8-hour exposure
Perceived thirst (Thirst Sensation Scale)
Ramy czasowe: End of 8-hour exposure

Perceived thirst assessed using the Thirst Sensation Scale, a single-item 9-point numerical rating scale on which participants respond to the question "How thirsty do you feel now?" Scores range from a minimum of 1 to a maximum of 9, with verbal anchors at 1 (not thirsty at all), 3 (a little thirsty), 5 (moderately thirsty), 7 (very thirsty), and 9 (very, very thirsty).

End of 8-hour exposure
Thermal sensation (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal sensation scale)
Ramy czasowe: End of 8-hour exposure

Thermal sensation assessed using the thermal sensation scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 7-point bipolar rating scale on which participants respond to the question "How do you feel right now?" Scores range from a minimum of -3 (cold) to a maximum of +3 (hot), with 0 indicating a neutral thermal sensation.

End of 8-hour exposure
Thermal comfort (American Society of Heating, Refrigerating and Air-Conditioning Engineers thermal comfort scale)
Ramy czasowe: End of 8-hour exposure

Thermal comfort assessed using the thermal comfort scale defined in ANSI/ASHRAE Standard 55 (American Society of Heating, Refrigerating and Air-Conditioning Engineers), a single-item 4-point rating scale on which participants respond to the question "How comfortable do you feel right now?" Scores range from a minimum of 1 (comfortable) to a maximum of 4 (very uncomfortable).

End of 8-hour exposure
Change in plasma volume
Ramy czasowe: End of 8-hour exposure

Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill

End of 8-hour exposure
Fluid loss
Ramy czasowe: End of 8-hour exposure

Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption)

End of 8-hour exposure
Fluid consumption
Ramy czasowe: End of 8-hour exposure

Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

End of 8-hour exposure
Heart rate variability: RMSSD
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

At the start (hour 0) and end of exposure (hour 8)
Heart rate variability: SDNN
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the seated position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of seated rest).

At the start (hour 0) and end of exposure (hour 8)
Rate pressure product
Ramy czasowe: End of 8-hour exposure

Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.

End of 8-hour exposure
Diastolic blood pressure
Ramy czasowe: End of 8-hour exposure

Diastolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

End of 8-hour exposure
Systolic blood pressure
Ramy czasowe: End of 8-hour exposure

Systolic blood pressure measured in triplicate via automated oscillometry (~60 seconds between measures)

End of 8-hour exposure
Systolic Response to Standing From Supine
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).

At the start (hour 0) and end of exposure (hour 8)
CDC 4-Stage Balance Test (Postural stability)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).

At the start (hour 0) and end of exposure (hour 8)
Executive function (cognitive function)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of executive function. Participants will complete the Cued Stroop test, in which they are presented a sequence of congruent, neutral and incongruent colour-word tasks.

At the start (hour 0) and end of exposure (hour 8)
Memory recall (cognitive function)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.

At the start (hour 0) and end of exposure (hour 8)
Impulse control (cognitive function)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.

At the start (hour 0) and end of exposure (hour 8)
Reaction time (cognitive function)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue.

At the start (hour 0) and end of exposure (hour 8)
Cardiac response to standing from supine (30:15 Ratio)
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). Assessment is performed in the morning prior to and following daytime exposure.

At the start (hour 0) and end of exposure (hour 8)
Heart rate (AUC)
Ramy czasowe: End of 8-hour exposure

Area under the curve of heart rate (in bpm-hours)

End of 8-hour exposure
Heart rate (Peak)
Ramy czasowe: End of 8-hour exposure

Peak Heart rate (15-min average) during the 8-hour exposure

End of 8-hour exposure
Core temperature (AUC)
Ramy czasowe: End of 8-hour exposure

Area under the curve of rectal temperature (in degree-hours)

End of 8-hour exposure
Core temperature (hourly)
Ramy czasowe: Hourly during the 8-hour exposure

Rectal temperature measured at each hour of exposure (15-min average)

Hourly during the 8-hour exposure
Mean skin temperature (Peak)
Ramy czasowe: End of 8-hour exposure

Peak mean skin temperature (15-min average) during the 8-hour exposure

End of 8-hour exposure
Mean skin temperature (AUC)
Ramy czasowe: End of 8-hour exposure

Area under the curve of mean skin temperature (in degree-hours)

End of 8-hour exposure
Urine specific gravity
Ramy czasowe: At the start (hour 0) and end of exposure (hour 8)

Urine specific gravity measured by handheld refractometer

At the start (hour 0) and end of exposure (hour 8)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Dyrektor Studium: Glen P Kenny, PhD, University of Ottawa

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

13 października 2026

Zakończenie podstawowe (Szacowany)

31 maja 2027

Ukończenie studiów (Szacowany)

31 maja 2027

Daty rejestracji na studia

Pierwszy przesłany

25 września 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

25 września 2026

Pierwszy wysłany (Rzeczywisty)

1 października 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

5 października 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

1 października 2026

Ostatnia weryfikacja

1 sierpnia 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj